AU2005339110A1 - Docosahexaenoic acid (DHA) producing thraustochytrid strain - SC1 - Google Patents
Docosahexaenoic acid (DHA) producing thraustochytrid strain - SC1 Download PDFInfo
- Publication number
- AU2005339110A1 AU2005339110A1 AU2005339110A AU2005339110A AU2005339110A1 AU 2005339110 A1 AU2005339110 A1 AU 2005339110A1 AU 2005339110 A AU2005339110 A AU 2005339110A AU 2005339110 A AU2005339110 A AU 2005339110A AU 2005339110 A1 AU2005339110 A1 AU 2005339110A1
- Authority
- AU
- Australia
- Prior art keywords
- dha
- acid
- strains
- producing
- omega
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000020669 docosahexaenoic acid Nutrition 0.000 title claims description 59
- 241001467333 Thraustochytriaceae Species 0.000 title description 31
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 title description 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 title description 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 title description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 112
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 55
- 150000004665 fatty acids Chemical class 0.000 claims description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 20
- 229930195729 fatty acid Natural products 0.000 claims description 20
- 239000000194 fatty acid Substances 0.000 claims description 20
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 18
- 244000005700 microbiome Species 0.000 claims description 12
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 11
- 108020004463 18S ribosomal RNA Proteins 0.000 claims description 10
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 8
- 241000233675 Thraustochytrium Species 0.000 claims description 4
- 239000000543 intermediate Substances 0.000 claims 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 31
- 238000004519 manufacturing process Methods 0.000 description 22
- 241000251468 Actinopterygii Species 0.000 description 9
- 235000019688 fish Nutrition 0.000 description 9
- 229940013317 fish oils Drugs 0.000 description 8
- 239000002028 Biomass Substances 0.000 description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 210000003705 ribosome Anatomy 0.000 description 6
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 5
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241000120622 Rhizophoraceae Species 0.000 description 4
- 241000233671 Schizochytrium Species 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108020001027 Ribosomal DNA Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000592342 Tracheophyta Species 0.000 description 3
- 210000001787 dendrite Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000598397 Schizochytrium sp. Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N n-heptadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 241000200158 Amphidinium Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000199913 Crypthecodinium Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000862501 Kandelia candel Species 0.000 description 1
- 241001491672 Labyrinthulaceae Species 0.000 description 1
- 241000276495 Melanogrammus aeglefinus Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000519590 Pseudoalteromonas Species 0.000 description 1
- 240000002044 Rhizophora apiculata Species 0.000 description 1
- 240000003793 Rhizophora mangle Species 0.000 description 1
- 241000276448 Salvelinus namaycush Species 0.000 description 1
- 241000233673 Schizochytrium aggregatum Species 0.000 description 1
- 241000863430 Shewanella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 241001298226 Ulkenia sp. Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical class CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 244000059217 heterotrophic organism Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
- C12N1/105—Protozoal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
- C12N1/125—Unicellular algae isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/89—Algae ; Processes using algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/90—Protozoa ; Processes using protozoa
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Description
WO 2007/068997 PCT/IB2005/003934 Docosahexaenoic acid (DHA) Producing Thraustochytrid Strain - SC1 Field of Invention: The invention relates to the screening of a novel unreported strain of Thraustochytrid SC1 producing comparable amounts of Docosahexaenoic acid isolated from the backwaters of Goa by the Pollen baiting method. The fatty acid profiles of the isolated organism indicating the production of the omega-3 fatty acids in significant amounts are disclosed. Also revealed is the 18S rRNA sequence of the isolated organisms indicative of their molecular phylogeny. Background of Invention: Interest in the nutritional importance of polyunsaturated fatty acids (PUFAs) has increased markedly during the past decade. Polyunsaturated fatty acids are long chain fatty acids containing two or more double bonds. Interest in them arises from their potential in therapeutic, food and nutritional applications. They are produced commercially from the selected seed plants and some marine sources. But the production of the purified PUFAs from the current sources will become inadequate for supplying the expanding market ( Gill and Valivety 1997). In order to meet the expected rise in demand and to circumvent the drawbacks of fish oils, alternative production processes for the PUFAs are currently being developed. PUFAs are grouped in 2 series on the basis of the position of the terminal bond being 3C or 6C from the terminal carbon atom of the fatty acid chain. They are generally classified into 2 main groups, the omega-6 (w6 or n-6) and omega-3 (w3 or n-3 series). Of the omega-6 fatty acids, arachidonic acid is gaining particular importance as it is the major precursor of many prostaglandins and eicosanoids and among the omega-3 fatty acids, Docosahexaenoic acid is currently receiving much attention and have been termed as "Essential Fatty Acids". 1 WO 2007/068997 PCT/IB2005/003934 Docosahexaenoic acid (DHA), the unsaturated, 22-carbon long, omega-3 fatty acid is commonly found in fish and marine plants. It has gained major significance owing to the fact that it is the major building block of the human brain tissue and is the primary structural fatty acid in the gray matter of the brain and in the retina. Recent findings have shown a correlation between low levels of DHA and certain behavioral and neurological conditions associated with aging such as dementia, depression, memory loss and visual problems demonstrating the physiological importance of DHA for humans. The WHO recently has recommended to cover 1-2 % of the daily intake of energy from the omega-3 fatty acids corresponding to about 2.2 to 4.4 g daily based on the 2000 calorie diet intake. The intake of omega-3 PUFAs via our diet occurs mainly through the consumption of sea food, which is characteristically rich in omega-3 PUFAs. The average intake varies among the populations. This strong demand has resulted in the introduction of large scale marine fish farms and the normal growth and development of several marine fish larvae depend on the supplementation of the omega-3 polyunsaturated fatty acids in the diet especially DHA and eicosapentaenoic acid (Rodriguez et al. 1998) At present selected fish oils and microalgal species are the main industrial sources of DHA. Fish oils with the highest levels of EPA and DHA include mackerel, herring and Salmon. Some fish such as cod, haddock, store most of the fat in the liver. The best sources though are cold-water fish such as tuna, mackerel, sardines, herring and lake trout. But to obtain the maximum benefits of DHA from fish dils, one has to preferably eat raw fish or boiled fish and moreover one should eat the skin behind the gills around the fins and along the belly as these areas are where most of the oil is stored. It must be pertinently noted that light, heat and oxygen all diminish the EPA and DHA in fish oils. Because fish oils are highly polyunsaturated, they become rancid quickly. Rancid fish smell fishy and hence are not very appetizing. The application of PUFAs from fish oils or their inclusion in infant formulas also has many disadvantages. Fish oils generally contain eicosapentanoic acid, an undesirable component in infant formulas because it leads to reduced arachidonic acid levels in infants. This has been correlated with the reduced rates of infant weight gain. 2 WO 2007/068997 PCT/IB2005/003934 Also, supplies of fish oil may be unreliable due to failure or variability of various fisheries. There is concern that sufficient fish oil will not be available to meet the global demands of DHA. As an alternative to fish oil, PUFAs can be obtained from microorganisms. In particular, the marine algae are thought to be the primary producers of the omega-3 polyunsaturated fatty acids in the marine food chain. These marine microorganisms represent the greatest percentage of the undescribed marine species (Colwell 1997) of which the marine microalgae form a large potential source of Docosahexaenoic acid. The potential source of n-3 oils is the group of micro-heterotrophs called Thraustochytrids. These are a group of non-photosynthetic, heterotrophic organisms presently classified under the Stramenophila kingdom, together with oomycetes and labyrinthulids. Members of the genera Schizochytrium and Thraustochytrium have been studied as potential omega-3 producers for industrial use due to their high lipid content and high levels of DHA. These species are sometimes also classified as marine fungi. Thraustochytrids are the common name of the microheterotrophs that feed as saprobes or occasionally as parasites. Thraustochytrids have a wide geographical distribution with strains isolated from Antarctica, North Sea, India, Japan and Australia. (Reviewed by Lewis et al., 1999).They are rarely found on living plants and appear to be inhibhited by plant anti-microbial agents. Members of these groups are often abound on dead autochthonous as well as allochthonous plant material such as macro algae and submerged Mangrove leaves. They are common in the neritic and the oceanic water column and the sediments including the deep sea. Compared to fish oils, microbes can provide a stable supply of fatty acids that can easily mass produced, have a less fishy smell and highly purified DHA and other PUFAs. Several recent studies have catalogued the ability of thraustochytrids strains to produce 1. A high biomass in culture 2. A high proportion of lipid as a part of this biomass 3. A high proportion of the PUFAs in the lipid Most reports concerning the production of PUFAs by Thraustochytrids have dealt almost exclusively with DHA production as this compound is the most abundant PUFA produced by many of the strains of thraustochytrids reported to date. 3 WO 2007/068997 PCT/IB2005/003934 High levels of DHA are also found in dinoflagellates, such as Crypthecodinium cohni and the Amphidinium species. Data available in the scientific literature demonstrate the large variation in biomass, lipid and maximum DHA yields obtained for different Thraustochytrid strains. For example, Schizochytrium aggregatum produced a biomass of 0.9g per litre after 10days (Vazhappilly and Chen,1998), while a biomass of 48g per litre after 4 days was achieved using Schizochytrium sp. SR21 (yaguchi et al., 1997). It is very clear that development of a microbial PUFA production process requires the selection of the proper microorganism and the optimized culture techniques. To achieve an increased production of PUFA rich products, the following key strategies need to be negotiated: 1. Further isolation, screening and the maintenance of PUFA-producing strains: Several strains with the potential for the commercial production of DHA-rich oils have already been isolated. However, if thraustochytrids that produce higher PUFA yields and /or more attractive PUFA profiles can be isolated and optimized. Demands for these isolates and the compounds may well increase. 2. Optimisation of efficiency of PUFA production: The types and the amounts of the PUFAs produced by individual strains of thraustochytrids are susceptible to manipulation by varying culture conditions. Enhancement of the PUFA profiles using molecular techniques may also be considered. Different markets will provide demand for strains that produce high levels of PUFAs measured either in terms of the biomass ( i.e., PUFA production w/w cell mass) or volume (i.e., Production w/v fermentation medium). 3. Schizochytrium sp. is used to produce DHA by heterotrophic cultivation (OmegaTech, Boulder, Colorado, USA). A major drawback of the Schizochytrium strains is the production of the omega-6 docosapentaenoic acid (DPA) in the microbial oils, in addition to DHA (Nakhara et al. 1996: Yokochi et al.1998: Ratledge 2001). The nutraceutical properties of DPA are currently not well known and therefore its presence in oils for food and pharmaceutical applications is undesirable. Separation of DPA from DHA is difficult and expensive. 4 WO 2007/068997 PCT/IB2005/003934 The present invention relates to the isolation of several strains of thraustochytrids, a few strains of which produce significant amounts of Docosahexaenoic acid (DHA; C22:6, n 3) that were screened from the dead leaves and dendrites of marine vascular plants called Mangroves collected from the backwaters of Goa. These strains will have major significance for the commercial production of Docosahexaenoic Acid. Prior Art: Huang et al., have described the grouping of newly isolated docosahexaenoic acid producing thraustochytrids based on their polyunsaturated fatty acid profiles and the comparative analysis of the 18S rRNA genes. Seven strains of marine microbes producing a significant amount of DHA were screened from the seawater collected in coastal areas of Japan and Fiji. They accumulate their intermediate respiratory intermediate fatty acids in addition to DHA. These isolates were proved to be new thraustochytrids by their specific insertion sequences in the 18S rRNA genes. The phylogenetic tree constructed by the molecular analysis of the 18S rRNA genes from the isolates and the typical thraustochytrids shows that the strains with the same PUFA profile form each monophyletic cluster. These results suggest that the C20-22 PUFA profile may be appreciable as an eefective characteristic for grouping thraustochytrids. Fan et al., have published in the Journal of Industrial Microbiology & Biotechnology (2001) the article describing Eicosapentaenoic acid and Docosahexaenoic acids production by nine thraustochytrids strains and the okara-utilizing potential of the thraustochytrids. These thraustochytrids strains have been isolated from the subtropical mangroves and were screened for the production potential of the above fatty acids in glucose yeast medium. Their ability to utilize okara (Soymilk residue) for growth and EPA and DHA production was also evaluated. The EPA yield was low in most of the strains, while DHA level was high on the glucose yeast ext. medium producing 28.1 41.1% of the total fatty acids, for all strains, with the exception of the Ulkenia sp. KF 13. The DHA yield of the Schizochytrium mangrovie ranged from 747.7 to 2778.9 mg/L after 52 hours of fermentation at 25C. 5 WO 2007/068997 PCT/IB2005/003934 The publication titled "Profiles of polyunsaturated fatty acids produced by Thraustochytrium sp KK17-3 " relates to the isolation of more than 300 strains of microorganisms producing polyunsaturated fatty acids (PUFA) were newly isolated from the coastal seawater in the Seto Inland Sea and around the Iromote Island, Japan, by the baiting method. The profiles of PUFA from the DHA producing strains were classified into four types. A strain named KK17-3 was then chosen for further study owing to its high DHA content.(52.1% of the total fatty acid.) and a wide range of other PUFAs including arachidonic, eicosapentaenoic acid and docosapentaenoic acid as well as DHA. Molecular phylogenetic analysis of the 18S rRNA gene sequences showed KK17-3 to be a thraustochytrids. Yet another publication by Bowles et al., relates to Long chain n-3 polyunsaturated fatty acid production by members of the marine protistan group of thraustochytrids. Screening of the isolates were undertaken followed by the optimization of DHA production. The isolation program was undertaken from three different locations, 57 isolates were screened for their biomass, oil and docosahexaenoic acid production (DHA). DHA represented 50% of the total fatty acids present in these isolates. Some of the studies have also indicated that a medium of high C:N ratio stimulated DHA production . The optimum DHA production was 2.17 g per litre after 107 hours of cultivation. The publication titled " Fatty acid composition and the Squalene content of the Marine micro algae Schizochytrium mangrovie ". This publication relates to the identification of the fatty acid composition and the squalene content in the thraustochytrids S.mangrovie that was newly isolated from the decaying Kandelia candel leaves in the Hong Kong mangrove habitat. The major fatty acid constituents in all the three mangrovie strains were tetradecanoic acid, hexadecanoic acid, docosapentanoic acid, and docosahexaenoic acid. DHA was the most predominant polyunsaturated fatty acid and the percentage of DHA (of total fatty acids) in all these strains varied from 32.29 to 39.14%. 6 WO 2007/068997 PCT/IB2005/003934 The patent No WO9801536 describes the microorganisms belonging to the genus Shewanella or pseudoalteromonas which can produce docosahexaenoic acid within a short culture period. Our invention relates to identification of 10 unreported strains of Thraustochytrids inhabiting in the dead leaves and the dendrites of marine vascular plants called Mangroves from the backwaters of Goa. Subsequent to isolation, GC-MS analysis for the organisms were carried out to determine their total fatty acid content. The 18S rRNA sequences of these organisms indicate their phylogeny. On futher study, these organisms can be efficient large scale producers of Docosahexaenoic acid. Figures: Fig. 1 Fatty acid profile of different strains of Thraustochytrids Sequence Listings: Seq ID 1: represents the 18S rRNA sequence of SC1 Seq ID 2: represents the 18S ribosomal sequence of AVE 1 Seq ID 3: represents the 18S ribosomal sequence of AVE2 Seq ID 4: represents the 18S ribosomal sequence of AVE3 Seq ID 5: represents the 18S ribosomal DNA sequence of AVE4 Seq ID 6: represents the 18S ribosomal DNA sequence of AVE5 Seq ID 7: represents the 18S ribosomal sequence of AVE6 Seq ID 8: represents the 18S ribosomal sequence of AVE7 Seq ID 9: represents the 18S ribosomal DNA sequence of AVE8. Seq ID 10: represents the 18S ribosomal sequence of AVE9. 7 WO 2007/068997 PCT/IB2005/003934 Detailed description of the Invention: Thraustochytrium strains are inhabited in the dead leaves and dendrites of marine vascular plants called Mangroves. Dead leaves from these plants were collected from the backwaters of Goa and isolated by pollen baiting method. The leaves were cultured in sterile seawater with antibiotics (streptomycin and penicillin) and. pine pollen grains for three days. These pollens were re-inoculated into fresh sterile seawater with antibiotics. After 3 days of incubation the pollens were examined under the microscope. 10 different strains of thraustochytrids were found and these were plated on MV (Rock salt -3.4%, Peptone - 0.15%, Yeast Extract- 0.1%, Glucose-2%, KH 2
PO
4 - 0.025%, pH 7) agar plate for 5 days with antibiotics. The thraustochytrids form colony/ layer on the plate. These Thraustochytrids were inoculated in fresh MV media with antibiotics. After 3 days of growth the pure culture were obtained. Thraustochytrids were cultured for a period of 5 days and the cells subjected to GC-MS analysis for determining the total fatty acid content. Screening of thraustochytrids for identifying strains which produce high amounts of DHA. Total lipid was extracted from the cultures using Folch method of extracting with 2:1 v/v of chloroform: methanol. For quantification of total lipid as well as individual fatty acids, an internal standard (heptadecanoic or pentadecanoic acid) was added before extraction. Fatty acids were extracted, esterified and GC-MS analysis was carried out with Agilent 6890 N gas chromatograph connected to Agilent 5973 mass spectrometer and GC on HP 6850 Series gas chromatograph equipped with a FID detector. The GC-MS detection was performed at 70 eV (m/z 50-550; sourc€at 230 oC and quadruple at 150 oC) in the El mode with a capillary column (30 m, HP-5ms, WCOT, i.d. 0.25 mm, film thickness 0.25 lm, oven 2 min at 150 'C, 6 oC min 1 to 300 oC, 20 min at 300 'C, Helium carrier gas flow, 1.0 ml/min, split ratio 50:1). For GC-FID, the capillary column DB-23 (30m, 8 WO 2007/068997 PCT/IB2005/003934 WCOT, i.d. 0.25 mm, film thickness 0.5 pm) was used. The oven temperature was programmed as 2 min at 160 'C, 6 'C mind to 180 oC, 2 min at 180 oC, 4 'C min -1 to 230 oC and 10 min at 230 oC, with N 2 carrier gas flow, 1.5 ml/min, and injector temp at 230 oC and detector temp at 250 oC; split ratio 50:1. The fatty acid profile of the 10 strains isolated is represented in the Fig.1 The fatty acid profile of these strains suggests that the AVE5, AVE7 and SC-1 produce comparable amounts of DHA. AVE1 is also a fair producer of DHA. However, the other strains do not produce large amounts of DHA. 18s rRNA sequencing of the Thraustochytrids 1.7kb 18s rRNA sequence of SC-1, AVE5 and AVE7 which had high DHA content was amplified from the genomes using primers to the conserved regions. The amplified fragment was sequenced. The sequences are represented in the sequence listing. Thus the three strains - SC-1, AVE5 and AVE7 are seen to be producers of DHA These strains have been deposited at the Microbial Type Culture Collection and Gene Bank (MTCC), Institute of Microbial Technology (IMTECH) ,Chandigarh, India. These organisms on further study can prove to be very efficacious in the commercial production of DHA in large amounts. 9
Claims (7)
1. The microorganisms producing Docosahexanoic acid (DHA) and other omega-3 fatty acid/ fatty acid intermediates selected from the group comprising the genus Thraustochytrium.
2. The omega-3 fatty acid producing microorganisms of Claiml, comprising the 18S RNA sequence represented by the SEQ ID 1.
3. The omega-3 fatty acid producing microorganisms according to Claim 2, producing greater than 30% of Docosahexaenoic acid.
4. The omega-3 fatty acid producing microorganisms according to Claim 2, producing greater than 25% of Docosahexaenoic acid.
5. The omega-3 fatty acid producing microorganisms according to Claim 2, producing greater than 20% of Docosahexaenoic acid.
6. The omega-3 fatty acid producing microorganisms according to Claim 2, producing greater than 15% of Docosahexaenoic acid.
7. The omega-3 fatty acid producing microorganisms according to Claim 2, producing greater than 10% of Docosahexaenoic acid. 12
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/003934 WO2007068997A2 (en) | 2005-12-16 | 2005-12-16 | Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2005339110A1 true AU2005339110A1 (en) | 2007-06-21 |
Family
ID=37890412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005339110A Abandoned AU2005339110A1 (en) | 2005-12-16 | 2005-12-16 | Docosahexaenoic acid (DHA) producing thraustochytrid strain - SC1 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1963481A2 (en) |
JP (1) | JP2009519032A (en) |
CN (1) | CN101370929A (en) |
AU (1) | AU2005339110A1 (en) |
BR (1) | BRPI0520823A2 (en) |
CA (1) | CA2639071A1 (en) |
IL (1) | IL192162A0 (en) |
MX (1) | MX2008007860A (en) |
WO (1) | WO2007068997A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1899453B1 (en) | 2005-06-07 | 2013-12-18 | Ocean Nutrition Canada Limited | Eukaryotic microorganisms for producing lipids and antioxidants |
US9023616B2 (en) | 2006-08-01 | 2015-05-05 | Dsm Nutritional Products Ag | Oil producing microbes and method of modification thereof |
EP2367950B1 (en) | 2008-12-01 | 2017-03-29 | Universität des Saarlandes | Production of omega-3 fatty acids by myxobacteria |
EP2401386A4 (en) * | 2009-02-25 | 2013-03-13 | Vb Medicare Pvt Ltd | Improved methods for fermentative production of docosahexaenoic acid |
US8207363B2 (en) | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
JP5920890B2 (en) * | 2010-01-19 | 2016-05-18 | ディーエスエム アイピー アセッツ ビー.ブイ. | Eicosapentaenoic acid producing microorganisms, fatty acid compositions, and methods for making them and their use |
KR101147451B1 (en) * | 2010-05-04 | 2012-05-21 | 한국생명공학연구원 | Method for Culturing Microalgae Thraustochytrid |
EP2390343A1 (en) | 2010-05-31 | 2011-11-30 | InterMed Discovery GmbH | Production of fatty acids by heterologous expression of gene clusters from myxobacteria |
JP2014520574A (en) * | 2011-07-21 | 2014-08-25 | ディーエスエム アイピー アセッツ ビー.ブイ. | Microbial oil enriched with polyunsaturated fatty acids |
US9222112B2 (en) | 2011-07-21 | 2015-12-29 | Dsm Ip Assets B.V. | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
EP2947141B1 (en) * | 2013-01-18 | 2019-11-06 | Kyowa Hakko Bio Co., Ltd. | Microorganisms producing docosahexaenoic acid and utilization thereof |
FR3001736B1 (en) * | 2013-02-06 | 2016-03-04 | Roquette Freres | BIOMASS OF MICROALGUE SCHIZOCHYTRIUM MANGROVEI AND METHOD FOR PREPARING THE SAME |
PT2970926T (en) | 2013-03-13 | 2018-03-22 | Dsm Nutritional Products Ag | Engineering microorganisms |
CN103725617A (en) * | 2014-01-01 | 2014-04-16 | 北京大学深圳研究生院 | Aurantiochytrium sp. rich in glyceride type DHA (Docosahexaenoic Acid) and application thereof |
CN113278529B (en) * | 2014-05-22 | 2023-10-10 | 合成基因组股份有限公司 | Rhizopus strain for producing docosahexaenoic acid |
EP3098318A1 (en) | 2015-01-24 | 2016-11-30 | Indian Oil Corporation Limited | Thraustochytrid based process for treating waste effluents |
AR104042A1 (en) | 2015-03-26 | 2017-06-21 | Mara Renewables Corp | HIGH-DENSITY PRODUCTION OF BIOMASS AND OIL USING GLUCEROL IN GROSS |
CN107849514A (en) | 2015-07-13 | 2018-03-27 | 玛拉可再生能源公司 | Strengthen the microalgae metabolism of xylose |
US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
BR112019012421A2 (en) | 2016-12-22 | 2020-02-27 | MARA Renewables Corporation | CULTURE, EUCHARIOTIC MICRO-ORGANISM, METHODS FOR MAKING A LIPID COMPOSITION AND FOR PRODUCING A BIOMASS RICH IN PROTEINS |
KR102100650B1 (en) * | 2018-06-29 | 2020-04-16 | 씨제이제일제당 주식회사 | Novel microalgal strain of Thraustochytrium genus, and producing polyunsaturated fatty acids using the same |
EP4180513A1 (en) * | 2021-11-15 | 2023-05-17 | Indian Oil Corporation Limited | An improved process for production of enriched algal biomass |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0969086A1 (en) | 1996-07-03 | 2000-01-05 | Sagami Chemical Research Center | Microorganisms producing docosahexaenoic acid and process for the production of docosahexaenoic acid |
JP4280158B2 (en) * | 2002-12-27 | 2009-06-17 | 富士フイルム株式会社 | Microorganisms capable of producing docosahexaenoic acid and use thereof |
US20050019880A1 (en) * | 2003-03-31 | 2005-01-27 | Council Of Scientific And Industrial Research | Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists |
-
2005
- 2005-12-16 AU AU2005339110A patent/AU2005339110A1/en not_active Abandoned
- 2005-12-16 EP EP05818740A patent/EP1963481A2/en active Pending
- 2005-12-16 BR BRPI0520823-8A patent/BRPI0520823A2/en not_active IP Right Cessation
- 2005-12-16 MX MX2008007860A patent/MX2008007860A/en not_active Application Discontinuation
- 2005-12-16 CA CA002639071A patent/CA2639071A1/en not_active Abandoned
- 2005-12-16 JP JP2008545118A patent/JP2009519032A/en active Pending
- 2005-12-16 CN CNA200580052523XA patent/CN101370929A/en active Pending
- 2005-12-16 WO PCT/IB2005/003934 patent/WO2007068997A2/en active Application Filing
-
2008
- 2008-06-15 IL IL192162A patent/IL192162A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007068997A3 (en) | 2007-08-16 |
WO2007068997A2 (en) | 2007-06-21 |
BRPI0520823A2 (en) | 2011-04-12 |
CN101370929A (en) | 2009-02-18 |
JP2009519032A (en) | 2009-05-14 |
MX2008007860A (en) | 2009-02-11 |
IL192162A0 (en) | 2008-12-29 |
CA2639071A1 (en) | 2007-06-21 |
EP1963481A2 (en) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005339110A1 (en) | Docosahexaenoic acid (DHA) producing thraustochytrid strain - SC1 | |
CN1977038B (en) | Method for the cultivation of microorganisms of the genus thraustochytriales by using an optimized low salt medium | |
CN103827289B (en) | Schizochytrium limacinum method of mutagenesis and its variant of generation | |
Perveen et al. | Isolation and characterization of a novel thraustochytrid-like microorganism that efficiently produces docosahexaenoic acid | |
Patel et al. | Emerging prospects of microbial production of omega fatty acids: recent updates | |
JP4344827B2 (en) | Method for producing phospholipids containing long-chain highly unsaturated fatty acids using microorganisms of the genus Schizochytrium | |
JP3425622B2 (en) | Cultures containing polyunsaturated fatty acids and methods for producing oils and fats containing polyunsaturated fatty acids using Labyrinthula | |
US20130096332A1 (en) | Method for increasing the content of docosahexaenoic acid in fat-containing materials or in fats and oils | |
CN102037130A (en) | Process for producing oils comprising PUFAs using microorganisms of the labyrinthulomycota order | |
US20170327851A1 (en) | Microalgae Aurantiochytrium sp. LA3 (KCTC12685BP) and Method for Preparing Bio-Oil Using the Same | |
Bagul et al. | Isolation of fast-growing thraustochytrids and seasonal variation on the fatty acid composition of thraustochytrids from mangrove regions of Navi Mumbai, India | |
Hakim | The potential of heterotrophic microalgae (Schizochytrium sp.) as a source of DHA | |
JP2006513713A (en) | A method to increase the content of polyunsaturated fatty acids in the probiotic progenitor | |
US20050019880A1 (en) | Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists | |
KR20080087820A (en) | Docosahexaenoic acid (dha) producing thraustochytrid strain-sc1 | |
CN108431203B (en) | Method for enriching protists with lipids enriched in polyunsaturated fatty acids, more particularly in the omega 3 class of polyunsaturated fatty acids, and implementation for producing these lipids | |
KR102023756B1 (en) | Novel microalgae Thraustochytrium sp. LA6 (KCTC 12389BP), and producing method for bio-oil by using thereof | |
KR102126441B1 (en) | Novel microalgae of Lobosphaera incisa K-1 and its use | |
Zhang | The diversity and biotechnological application of marine microbes producing Omega-3 fatty acids | |
Berryman | Isolation of marine protists for production of polyunsaturated fatty acids | |
Hakim | THE POTENTIAL OF HETEROTROPHIC MICROALGAE (Schizochytrium sp.) AS A SOURCE OF DHA Potensi Mikroalga Heterotroph (Schizochytrium sp.) sebagai Sumber DHA | |
MXPA06005296A (en) | Method for the cultivation of microorganisms of the genusthraustochytrialesby using an optimized low salt medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |